98%
921
2 minutes
20
The first surgical modalities to reduce aqueous humor production by damaging the ciliary body date back to the early twentieth century. Until recently, however, cyclodestructive procedures (e.g., cyclocryotherapy and transscleral diode laser photocoagulation) have been reserved as last option procedures in refractory glaucoma patients with poor visual potential. Emerging technologic innovation has led to the development of promising, safer and less destructive techniques, such as micropulse diode cyclophotocoagulation, endoscopic cyclophotocoagulation and ultrasound cyclodestruction. Consequently, an emerging paradigm shift is under way with the selection of these surgical options in eyes with less severe glaucoma and good visual potential. Although existing evidence has not, as yet, adequately defined the role and value of these procedures, their emergence is a welcome expansion of available options for patients with moderate-to-severe glaucoma. This article reviews the pertinent evidence on both established and evolving cyclodestructive techniques and describes their growing role in the management of glaucoma.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267695 | PMC |
http://dx.doi.org/10.1007/s12325-018-0837-3 | DOI Listing |
Vet World
March 2025
Ophthalmology Unit, Kasetsart University Veterinary Teaching Hospital, Bangkok 10900, Thailand.
Background And Aim: Glaucoma is a neurodegenerative disease characterized by elevated intraocular pressure (IOP) and can lead to irreversible blindness in dogs. Cyclocryotherapy, a cyclodestructive surgical technique, reduces IOP by damaging the ciliary body epithelium to decrease aqueous humor production. Limited data exist on its clinical outcomes and complications in canine patients.
View Article and Find Full Text PDFCurr Opin Ophthalmol
September 2025
Department of Ophthalmology, Stein and Doheny Eye Institutes, University of California Los Angeles, Los Angeles, California, USA.
Purpose Of Review: Neovascular glaucoma (NVG) is a severe secondary glaucoma precipitated by ocular ischemia and abnormal neovascularization, resulting in elevated intraocular pressure (IOP) and vision loss if not promptly addressed. This study evaluates recent advances in both medical and surgical management of NVG, focusing on strategies that integrate anti-vascular endothelial growth factor (VEGF) therapy, retinal ablation, and evolving surgical techniques.
Recent Findings: Anti-VEGF agents remain central to NVG treatment, with newer agents and combination regimens showing sustained neovascular suppression, alongside panretinal photocoagulation as an additional cornerstone in reducing neovascular drive.
Curr Eye Res
August 2025
Department of Ophthalmology 3, Quinze-Vingts National Ophthalmology Hospital, IHU FOReSIGHT, Paris, France.
Purpose: To review current therapeutic strategies and innovations in the management of refractory glaucoma, with a focus on recent advancements in implantable surgical devices.
Methods: A comprehensive literature search across PubMed, Embase, and Cochrane Library, included terms such as "refractory glaucoma," "posterior drainage implants," "cyclodestruction," and "minimally invasive glaucoma surgery." Articles discussing surgical and medical interventions, as well as device innovations, were included.
Am J Ophthalmol Case Rep
June 2025
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Purpose: To describe a case of Ahmed glaucoma valve (AGV) implantation in a patient with clinical hypotony. In this instance, the AGV helped to stabilize labile intraocular pressures (IOP) by introducing a new outflow pathway that could buffer against variable aqueous inflow.
Observation: Our patient presented with severe mixed mechanism glaucoma in his only seeing eye and had a history of failed prior angle surgeries, filtration surgery, and cyclodestructive procedures.
Ophthalmic Epidemiol
March 2025
Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Purpose: This study analyzes trends in glaucoma surgical management at the Eye & ENT Hospital of Fudan University over a 10-year period (2013-2023), focusing on the evolution of surgical practices and the adoption of new techniques.
Methods: A retrospective observational study was conducted using medical records of patients diagnosed with glaucoma who underwent surgery between January 1, 2013, and December 31, 2023. Data were analyzed using the Cochrane-Armitage trend test.